As of May 2022, Immunoway Biotechnology and Assay Biotechnology Company, Inc. have officially merged. Together, we will provide a complete immunological product line for life science users world-wide. Utilizing the combination of the ever-expanding and revolutionary innovations from both companies, plus Immunoway’s superior manufacturing capabilities and expanded marketing channels, we strive to provide every scientist in the world Immunoway products.
Our mission is to provide superior quality and highly validated Polyclonal Antibodies (pAbs), Monoclonal Antibodies (mAbs), genetically engineered antibodies, Sandwich ELISA kits, and Cell-Based ELISA kits for all life science research applications. We look forward to providing better immunological tools and becoming a world-class life science industry partner.